Radio and PodcastLive Radio & PodcastsScience & Medicine
Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition
Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Amanda Muir from the Department of Gastroenterology, Hep...
About This Episode
Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition is an episode from Gut podcast by BMJ Group. Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hos...
Podcast
This episode belongs to Gut podcast.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published May 6, 2026, 14:42 long, audio available.
Related Episodes
Continue listening to more episodes from Gut podcast.
Managing type 2 diabetes patients with MASLD
Mar 2, 2026 - 20:24
Targeting MASLD with new nanoparticles
Feb 2, 2026 - 14:58
Performance of the China-CLIF framework in acute-on-chronic liver failure
Jan 6, 2026 - 15:10
Effective treatment of severe acute pancreatitis using COX-2 inhibitors
Sep 5, 2025 - 18:01
Questions About This Episode
What is Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition about?
Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Amanda Muir from the Department of Gastroenterology, Hepatology, and Nutrition, The Children’s Hospital of Philadelphia, and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA, on the paper " FOXM1 inhibition reduces IL-13-induced epithelial remodelling and inflammation in eosinophilic oesophagitis " published in paper copy in Gut in May 2026. Please
Where can I listen to Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition?
You can listen to Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition from?
Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition is an episode from Gut podcast by BMJ Group.
How long is this episode?
This episode is 14:42 long.
When was this episode published?
This episode was published on May 6, 2026.
Can I save Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Gut podcast?
Yes. This page shows related episodes from Gut podcast when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition?
You can listen to Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition is from Gut podcast by BMJ Group.
What are the episode details?
Published May 6, 2026 and 14:42 long